An Urgent Need: A Broad Spectrum Virucidal Drug

Humanity is faced with a global health and economic crisis. The best clinical tools are antivirals that only temporarily slow the virus.

Nothing directly attacks the virus itself. 

Until now.

Maxwell’s world-first drug class attacks and irreversibly inactivates RNA and DNA viruses. This new approach has been validated in independent experiments at The National Institute of Infectious Disease (Japan’s CDC), Stanford, NYU and others against both RNA and DNA viruses. These preclinical lab tests show that Maxwell’s peptoid drug class is safe in cultured human lung and mouth cells, and in live mouse lungs and skin. It is effective at low doses. The preclinical safety data and the irreversible nature of the treatment make Maxwell’s new Peptoid drug class a potentially game-changing therapeutic.

 

Peptoid vs RNA virus

We Need a Safe, Long-Term Treatment

Maxwell’s novel, patented drug class (called “Peptoids”) mimics natural peptides used by all human white blood cells to attack viruses – Human Cathelicidin Antimicrobial Peptides, or more simply “LL-37.” For over 200 million years, LL-37 has successfully defended mammals against viruses without allowing viruses to develop significant resistance. Maxwell’s peptoids mimic LL-37’s virucidal properties, allowing peptoids to bind to the structure of viruses and irreversibly inactivate them – the biological equivalent of injecting a sticky glue (flocculation) into the internal gears of a complex machine. [Read More]

Peptoids Closely Resemble Human Peptides

Pioneered by Stanford and NYU researchers, Maxwell’s peptoids are biomimetics, meaning they mimic naturally safe and effective antiviral peptides. Maxwell’s peptoids have amino acid side chains attached at the nitrogen, instead of at the carbon. This makes our peptoids strongly resistant to the protease enzymes which many pathogens use to destroy carbon-based immune peptides. The additional strength in a peptoid’s nitrogen bond allows peptoids to fight viruses longer and harder than any known natural peptide. Read more about antimicrobial peptoids – poly-N-substituted glycine anti-infectives.

A Novel Mechanism of Action

Maxwell’s peptoids use a mechanism of action similar to natural human peptides to allow peptoids to be highly attracted to pathogens while avoiding human cells. Viruses, and many other pathogens, have a negative charge which attracts Maxwell’s positively-charged. Healthy human cells are neutrally charged and don’t attract our drugs.

Learn more about Maxwell’s peptoid drug class.